Soylu A.R.Dökmeci G.Tezel A.Amuca H.Ümit H.2024-06-122024-06-1220030002-9270https://doi.org/10.1111/j.1572-0241.2003.07507.xhttps://hdl.handle.net/20.500.14551/16350[No abstract available]en10.1111/j.1572-0241.2003.07507.xinfo:eu-repo/semantics/closedAccessCisapride; Furosemide; Propranolol; Spironolactone; Adult; Aged; Ascites; Bacterial Peritonitis; Bacterial Translocation; Controlled Study; Drug Mechanism; Escherichia Coli; Female; Human; Incidence; Letter; Liver Cirrhosis; Long Term Care; Major Clinical Study; Male; Priority Journal; Prophylaxis; Retrospective Study; Staphylococcus AureusPropranolol does not affect incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8]Letter986144614482-s2.0-003763517712818300Q1